TREATMENT RESULTS OF SEVERE PNEUMONIA IN CHILDREN AGED 2 MONTHS TO 5 YEARS AT THE HO CHI MINH CITY TROPICAL DISEASES HOSPITAL
Main Article Content
Abstract
Objectives: To review the treatment characteristics and treatment results of severe pneumonia in children aged 2 months to 5 years at the Ho Chi Minh city Tropical Diseases Hospital; and explore the related factors to the outcomes. Subjects and methods: Pediatric patients aged 2 to 59 months were diagnosed with severe community-acquired pneumonia and treated at Pediatrics Department D (respiratory department) of Ho Chi Minh city Tropical Diseases Hospital from October 2019 to October 2020. Evaluation of treatment results after 48 hours of admission. Results: Initial antibiotics: Ceftriaxone 92.8%, Cefoperazone/ Sulbactam (6%), combination of Ceftriaxone + Vancomycin (1.2%). Progression of initial antibiotic response: 95.2% response. do not respond 4.8%, must add or change antibiotics. Treatment results: Success 86.9%, failure 13.1%. Factors related to treatment outcome: Children with underlying disease have a lower success rate of treatment than the group without underlying disease (OR = 17.4, P<0.05). Children with a history of contact with a cough/runny nose in the past week had a lower success rate than the non-contact group (OR= 9, P<0.05). Conclusion: Pediatric pneumonia requires early diagnosis and treatment to reduce morbidity and mortality.
Article Details
Keywords
severe pneumonia, antibiotics, complications
References
2. Harris M, Clark J, Coote N, et al. (2011), British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011, Thorax, 66 Suppl 2(pp. ii1-23.
3. Jain DL, Sarathi V, Jawalekar S (2013), Predictors of treatment failure in hospitalized children [3-59 months] with severe and very severe pneumonia, Indian Pediatr, 50(8), pp. 787-9.
4. Jiang W, Wu M, Zhou J, et al. (2017), Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia, BMC Infect Dis, 17(1), pp. 787.
5. Liu JW, Chen YH, Lee WS, et al. (2019), Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia, Antimicrob Agents Chemother, 63(8), pp.
6. Igor Rudan aCB-P, b Zrinka Biloglav, c Kim Mulhollandd & Harry Campbelle (2008), Epidemiology and etiology of childhood pneumonia, Bulletin of the World Health Organization 86(5), pp. 408-416.
7. WHO (2005), Hospital care for children - Guidelines for the management of common childhood illnesses, Second edition, pp. pp. 80-91.